Reagent to confirm Lupus anticoagulant

Reagent to confirm Lupus anticoagulant

Lupus anticoagulant is the most common cause of acquired thrombophilia. The incidence of lupus anticoagulant in the general population is 1% to 2%. Chronic lupus anticoagulant is associated with a 30%...

Supplied by Bio/Data Corporation


Lupus anticoagulant is the most common cause of acquired thrombophilia. The incidence of lupus anticoagulant in the general population is 1% to 2%. Chronic lupus anticoagulant is associated with a 30% risk of venous thromboembolic disease or arterial thrombosis, including stroke and myocardial infarction, as well as with chronic spontaneous abortion. For use in the platelet neutralisation procedure (PNP), Lupus Anticoagulant Confirmation Reagent (LA-CR) is used to determine if the prolongation of an activated partial thromboplastin time (APTT) is due to the presence of lupus anticoagulant. The reagent is a lyophilised preparation of phosphatidyl enhanced platelet phospholipid, the addition of which will shorten the APTT time in the presence of the lupus anticoagulant. Thus, the platelet neutralisation procedure is a valuable diagnostic test to confirm lupus anticoagulant.


Contact form

Get in touch directly with the above supplier

Your email address will not be communicated to any third party other than the above supplier for the purpose of fulfilling this enquiry. For more information: read our privacy policy.